Please choose your territory and language

  • International
    • English
    • Deutsch
    • Français
    • Italiano
    • Español
  • Switzerland
    • Deutsch
    • Français
    • Italiano
  • Germany
    • Deutsch
  • Austria
    • Deutsch
  • France
    • Français
  • Italy
    • Italiano
  • Spain
    • Español
  • Benelux
    • Français
    • English
  • USA
    • English
    • Español
  • Australia
    • English
  • Scandinavia
    • English

This website uses cookies. By continuing to browse the website you are agreeing to our use of cookies. For more information, see our page 'Data privacy statement'.

Compare

Compare now

Please choose your territory and language

  • International
    • English
    • Deutsch
    • Français
    • Italiano
    • Español
  • Switzerland
    • Deutsch
    • Français
    • Italiano
  • Germany
    • Deutsch
  • Austria
    • Deutsch
  • France
    • Français
  • Italy
    • Italiano
  • Spain
    • Español
  • Benelux
    • Français
    • English
  • USA
    • English
    • Español
  • Australia
    • English
  • Scandinavia
    • English
Back to BMC Racing Team

BMC Racing Team: Statement Regarding Samuel Sánchez Anti-Doping Violation

4. October 2017, Santa Rosa, California (USA) — Road Team

(c) TDWSport.com

BMC Racing Team was previously informed by the Union Cycliste Internationale (UCI) of a potential anti-doping violation for the presence of GHRP-2 and its metabolite, in an out-of-race anti-doping control for Samuel Sánchez Gonzalez.

In accordance with BMC Racing Team’s zero tolerance policy with respect to doping violations and UCI regulations, Sánchez was immediately suspended from BMC Racing Team. At the request of Sánchez, his B sample was analysed at the WADA accredited laboratory in Lausanne, Switzerland. The analysis of Sánchez’ B sample confirmed the presence of GHRP-2 and its metabolite, as found in his A sample. At that time, Sánchez’ contract with the team was terminated with immediate effect. 

Innovation
International, English BMC SitesFind a retailerB2BContact